Multiresistant Neisseria gonorrhoeae : a new threat in second decade of the XXI century
Neisseria gonorrhoeae is an etiologic agent of gonorrhoea, one of the most common sexually transmitted diseases caused by bacteria. For many years, infections caused by N. gonorrhoeae were considered to be relatively easy to treat; however, resistance has emerged successively to all therapeutic agents used in treatment of the disease, e.g., penicillin, ciprofloxacin or azithromycin. Currently, the global problem is the emergence and a threat of spread of N. gonorrhoeae strains resistant to extended-spectrum cephalosporins (ESC), such as injectable ceftriaxone and oral-used cefixime. Especially, dangerous are multi-resistant strains resistant simultaneously to ESC and azithromycin. Three strains with high-level resistance to azithromycin and resistant to ESC were first time isolated in 2018. Moreover, in 2018, the first ESBL was described in N. gonorrhoeae and that makes the threat of appearing the ESBL mechanism of resistance in N. gonorrhoeae more real, even though the strain was sensitive to ceftriaxone. Molecular typing revealed that variants resistant to ESC occurred also among strains belonging to epidemic clonal complex CC1 (genogroup G1407) distinguished in NG-MAST typing system. The G1407 genogroup, in particular the ST1407 sequence type, is currently dominant in most European countries. The presence of different mechanisms of drug resistance significantly affects clinical practice and force changes in treatment regimens and introduction of new drugs.
| Errataetall: |
ErratumIn: Med Microbiol Immunol. 2020 Oct;209(5):641. - PMID 32382801 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:209 |
|---|---|
| Enthalten in: |
Medical microbiology and immunology - 209(2020), 2 vom: 01. Apr., Seite 95-108 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Młynarczyk-Bonikowska, Beata [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 29.12.2020 Date Revised 29.12.2020 published: Print-Electronic ErratumIn: Med Microbiol Immunol. 2020 Oct;209(5):641. - PMID 32382801 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00430-019-00651-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM304039063 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM304039063 | ||
| 003 | DE-627 | ||
| 005 | 20231225114124.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00430-019-00651-4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1013.xml |
| 035 | |a (DE-627)NLM304039063 | ||
| 035 | |a (NLM)31802195 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Młynarczyk-Bonikowska, Beata |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Multiresistant Neisseria gonorrhoeae |b a new threat in second decade of the XXI century |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.12.2020 | ||
| 500 | |a Date Revised 29.12.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumIn: Med Microbiol Immunol. 2020 Oct;209(5):641. - PMID 32382801 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Neisseria gonorrhoeae is an etiologic agent of gonorrhoea, one of the most common sexually transmitted diseases caused by bacteria. For many years, infections caused by N. gonorrhoeae were considered to be relatively easy to treat; however, resistance has emerged successively to all therapeutic agents used in treatment of the disease, e.g., penicillin, ciprofloxacin or azithromycin. Currently, the global problem is the emergence and a threat of spread of N. gonorrhoeae strains resistant to extended-spectrum cephalosporins (ESC), such as injectable ceftriaxone and oral-used cefixime. Especially, dangerous are multi-resistant strains resistant simultaneously to ESC and azithromycin. Three strains with high-level resistance to azithromycin and resistant to ESC were first time isolated in 2018. Moreover, in 2018, the first ESBL was described in N. gonorrhoeae and that makes the threat of appearing the ESBL mechanism of resistance in N. gonorrhoeae more real, even though the strain was sensitive to ceftriaxone. Molecular typing revealed that variants resistant to ESC occurred also among strains belonging to epidemic clonal complex CC1 (genogroup G1407) distinguished in NG-MAST typing system. The G1407 genogroup, in particular the ST1407 sequence type, is currently dominant in most European countries. The presence of different mechanisms of drug resistance significantly affects clinical practice and force changes in treatment regimens and introduction of new drugs | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Epidemic clones NG-MAST | |
| 650 | 4 | |a Gonorrhoea | |
| 650 | 4 | |a Mechanisms of antibiotic resistance | |
| 650 | 4 | |a Multiresistant Neisseria gonorrhoeae | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Penicillins |2 NLM | |
| 650 | 7 | |a Ciprofloxacin |2 NLM | |
| 650 | 7 | |a 5E8K9I0O4U |2 NLM | |
| 650 | 7 | |a Ceftriaxone |2 NLM | |
| 650 | 7 | |a 75J73V1629 |2 NLM | |
| 650 | 7 | |a Azithromycin |2 NLM | |
| 650 | 7 | |a 83905-01-5 |2 NLM | |
| 650 | 7 | |a Cefixime |2 NLM | |
| 650 | 7 | |a 97I1C92E55 |2 NLM | |
| 700 | 1 | |a Majewska, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Malejczyk, Magdalena |e verfasserin |4 aut | |
| 700 | 1 | |a Młynarczyk, Grażyna |e verfasserin |4 aut | |
| 700 | 1 | |a Majewski, Sławomir |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Medical microbiology and immunology |d 1971 |g 209(2020), 2 vom: 01. Apr., Seite 95-108 |w (DE-627)NLM000278424 |x 1432-1831 |7 nnns |
| 773 | 1 | 8 | |g volume:209 |g year:2020 |g number:2 |g day:01 |g month:04 |g pages:95-108 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00430-019-00651-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 209 |j 2020 |e 2 |b 01 |c 04 |h 95-108 | ||